What's breaking now, across thousands of outlets.
WuXi Biologics and German drugmaker Fresenius have reached one of the largest biosimilar deals to date ahead of what some in the industry have called an upcoming “golden decade” for such products. ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Investigators didn’t know a man who showed up to a Toronto hospital last Thursday with a gunshot wound was wanted in a violent home invasion, Chief Myron Demkiw says.
A study led by researchers at the University of California San Diego School of Medicine and University of California, Riverside (UCR) School of Medicine has identified new targets for antiviral drugs…
Surgery should remain the primary treatment for people with early-stage non-small cell lung cancer (NSCLC) who are suitable for either surgery or a highly targeted form of radiotherapy, a new study…
NAIROBI, Kenya, Nov 2 – The Communications Authority of Kenya (CA) has launched a project to improve the delivery of vaccines and other temperature-sensitive medical supplies to health facilities in…
(MedPage Today) -- BALTIMORE -- Use of a combined GLP-1/GIP receptor agonist was associated with improved menstrual regularity, an analysis of a prospective cohort showed.
People signing up for health insurance coverage under the Affordable Care Act for 2027 should expect higher premiums and fewer options. The enrollment period starts Sunday and ends in mid-January.
